Castle Biosciences Supports Patient-Focused Initiatives for Skin Cancer Awareness Month

05/04/2022
Castle Biosciences Supports PatientFocused Initiatives for Skin Cancer Awareness Month image

Castle will collaborate with the Melanoma Research Foundation and The Skin Cancer Foundation in support of key advocacy events during the month of May.

Castle Biosciences, Inc. will continue its ongoing collaboration with the Melanoma Research Foundation (MRF) and The Skin Cancer Foundation to support skin cancer research, education and advocacy, highlighting events during May, in recognition of Skin Cancer Awareness Month.

“We are committed to improving the lives of patients diagnosed with skin cancer through our innovative portfolio of tests that are designed to guide their care and through our partnerships with organizations who share our passion for skin health,” says Derek Maetzold, president and chief executive officer of Castle Biosciences, in a news release. “MRF and The Skin Cancer Foundation are making fantastic strides in their advocacy efforts on behalf of the skin cancer patient community, and we are proud to support their efforts.”

This is the second consecutive year that Castle has collaborated with the MRF on two of their key educational and fundraising events taking place during the month of May and beyond, including:

  • “Ask the Expert” webinar on Tuesday, May 10, at 7 p.m. Eastern time, titled “What do I do next: A roadmap for care after an early-stage melanoma diagnosis.” Register here to access this upcoming session. For access to recorded playbacks of previous sessions, please visit the MRF YouTube channel.
  • MRF Miles for Melanoma 5K runs/walks are community events held across the U.S., both virtually and in-person, to raise funds that support critical research for viable melanoma treatments. Castle is proud to sponsor multiple walks across the U.S. in 2022. For more information and to get involved, visit MRF’s Miles for Melanoma page.

“It is estimated that almost 200,000 people in the U.S. will be diagnosed with melanoma this year, and it is our mission at the MRF to change that,” says Kyleigh LiPira, M.B.A., chief executive officer of the MRF. "Our work to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy is made possible through the continued partnership of generous, patient-focused companies like Castle Biosciences.”

The Skin Cancer Foundation

The Champions for Change Gala is The Skin Cancer Foundation’s signature fundraising event, being held on Thursday, May 12, in New York. Proceeds from this event, in which Castle is a sponsor, support the Foundation’s educational campaigns, community programs and research initiatives.

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free